EML4-ALK Fusion Lung Cancer: A Rare Acquired Event

Neoplasia - Tập 10 Số 3 - Trang 298-302 - 2008
Sven Perner1,2, Patrick Wagner1, Francesca Demichelis1,3, Rohit Mehra4, Christopher J. Lafargue1, Benjamin J. Moss1, Stefanie Arbogast5, Alex Soltermann5, Walter Weder6, Thomas J. Giordano7, David G. Beer8, David S. Rickman1, Arul M. Chinnaiyan9, Holger Moch5, Mark A. Rubin1
1Department of Pathology and Laboratory Medicine, Weill Cornell Medical Center, New York, NY, USA
2Department of Pathology, University Hospitals of Ulm, Ulm, Germany
3Institute for Computational Biomedicine, Weill Cornell Medical Center, New York, NY, USA
4Michigan Center for Translational Pathology, Department of Pathology, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA
5Institute of Surgical Pathology, Department of Pathology, University Hospital of Zurich, Zurich, Switzerland
6Division of Thoracic Surgery, University Hospital of Zurich, Zurich, Switzerland
7Department of Pathology, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA
8Section of Thoracic Surgery, Department of Surgery, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA
9Michigan Center for Translational Pathology, Department of Pathology, Urology, Bioinformatics, and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Mitelman, 2004, Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer, Nat Genet, 36, 331, 10.1038/ng1335

Tomlins, 2005, Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer, Science, 310, 644, 10.1126/science.1117679

Soda, 2007, Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer, Nature, 448, 561, 10.1038/nature05945

Amin, 2007, Pathobiology of ALK+ anaplastic large-cell lymphoma, Blood, 110, 2259, 10.1182/blood-2007-04-060715

Weir, 2007, Characterizing the cancer genome in lung adenocarcinoma, Nature, 450, 893, 10.1038/nature06358

Setlur S, Mertz K, Hoshida Y, Demichelis F, Lupien M, Perner S, Sboner A, Pawitan Y, Andren O, Johnson L, et al. TMPRSS2-ERG fusion prostate cancer is a molecularly distinct estrogen-sensitive subclass of aggressive prostate cancer. In revision.

Inamura, 2008, EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers, J Thorac Oncol, 3, 13, 10.1097/JTO.0b013e31815e8b60

Rikova, 2007, Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer, Cell, 131, 1190, 10.1016/j.cell.2007.11.025

Karamouzis, 2007, Update on the role of EGFR inhibitors in cancer therapeutics, Cancer Treat Res, 135, 257, 10.1007/978-0-387-69219-7_19

Perner, 2007, TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion, Am J Surg Pathol, 31, 882, 10.1097/01.pas.0000213424.38503.aa

Thông tin
Thông tin xuất bản

Neoplasia

Tập 10 Số 3

298-302

Thông tin tác giả